Evidence map›Paper›PMID 27843293›Full record

ArticleDrug design, development and therapy2016

The expression of HoxB5 and SPC in neonatal rat lung after exposure to fluoxetine.

Razieh Taghizadeh, Zahra Taghipour, Akbar Karimi, Ali Shamsizadeh, Mohammad Mohsen Taghavi, Mahdi Shariati, Ahmad Shabanizadeh, Hamid Reza Jafari Naveh, Reza Bidaki, Fariba Aminzadeh

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Razieh TaghizadehDepartment of Biology, Payame Noor University, Isfahan, Iran.
Zahra TaghipourDepartment of Anatomy, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Akbar KarimiDepartment of Biology, Payame Noor University, Isfahan, Iran.
Ali ShamsizadehDepartment of Physiology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Mohammad Mohsen TaghaviDepartment of Anatomy, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Mahdi ShariatiDepartment of Anatomy, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Ahmad ShabanizadehDepartment of Anatomy, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Hamid Reza Jafari NavehDepartment of Anatomy, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Reza BidakiShahid Sadoughi University of Medical Sciences, Yazd, Iran.
Fariba AminzadehRafsanjan University of Medical Sciences, Rafsanjan, Iran.
Rafsanjan University of Medical Sciences · IRPayame Noor University · IRShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveApproximately 10% of pregnant women suffer from pregnancy-associated depression. Fluoxetine, as a selective serotonin reuptake inhibitor, is being employed as a therapy for depressive disorders. The present study aimed to determine the effects of fluoxetine on neonatal lung development.

methodsThirty pregnant Wistar rats (weighing 200-250 g) were treated daily with 7 mg/kg fluoxetine from gestation day 0 to gestation day 21, via gavage. The control group received a similar volume of distilled water only. Following delivery, the newborns and their lungs were immediately weighed in both of the groups. The right lung was fixed for histological assessments while the left lung was used for evaluation of the expression of SPC and HoxB5 by the real-time polymerase chain reaction method.

resultsResults have indicated that even though the body weight and the number of neonatal rats in both groups were the same, the lung weight of neonates exposed to fluoxetine was significantly different compared to the control group (

conclusionAccording to the upregulated expression of HoxB5 concerning histological findings, results of the present study showed that fluoxetine can influence lung growth and may in turn lead to delay in lung development. So establishment of studies to identify the effects of antidepressant drugs during pregnancy is deserved.

Indexed as

AnimalsAnimals, NewbornAntidepressive AgentsFemaleFluoxetineLungPregnancyRatsRats, WistarReal-Time Polymerase Chain ReactionSelective Serotonin Reuptake InhibitorsAntidepressive AgentsFluoxetineSelective Serotonin Reuptake InhibitorsfluoxetineHoxB5lungratSPC

Identifiers

PMID27843293
PMCPMC5098522
OpenAlexW2547905452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.